- €2.93bn
- €3.11bn
- €1.46bn
Brief: Virbac Sees 2026 Targets At Upper End Of Range
Bernstein lifts Virbac to 'outperform', as Supercharge portfolio boosts margins
French and Benelux stocks-Factors to watch on September 18
Virbac confirms outlook as Supercharge platforms drive profit growth
Brief: Virbac SA - H1 EBIT Adjusted EUR 144.2 Million
Virbac reports 6.8% rise in first-half core profit
Virbac rises after H1 sales beat, confirmed outlook
Veterinary drugmaker Virbac's H1 revenue rises on Supercharge platform strength
Brief: Virbac Q2 Revenue €384 Million, 2026 Outlook Confirmed
Europe Research Roundup: Boliden, Central Asia Metals, Wolters Kluwer
Virbac shares rise on strong Q1 revenue growth
French and Benelux stocks-Factors to watch April 17
Animal vaccine firm Virbac's Q1 revenue rises on North America performance
Brief: Virbac Q1 Revenue EUR 384 Mln, Maintains 2026 Guidance
French and Benelux stocks-Factors to watch
Brief: Virbac FY Revenues EUR 1.46 Bln
French and Benelux stocks-Factors to watch
France's Virbac 2025 revenue up 7.9% at constant rates
Brief: Virbac Sees Revenue Growth Between 5.5% And 7.5% For 2026